Bill Text: WA HB1689 | 2021-2022 | Regular Session | Comm Sub
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Exempting biomarker testing from prior authorization for patients with late stage cancer.
Spectrum: Slight Partisan Bill (Democrat 6-2)
Status: (Passed) 2022-03-24 - Effective date 6/9/2022. [HB1689 Detail]
Download: Washington-2021-HB1689-Comm_Sub.pdf
Bill Title: Exempting biomarker testing from prior authorization for patients with late stage cancer.
Spectrum: Slight Partisan Bill (Democrat 6-2)
Status: (Passed) 2022-03-24 - Effective date 6/9/2022. [HB1689 Detail]
Download: Washington-2021-HB1689-Comm_Sub.pdf